Indian Institute of Public Health -Delhi, Public Health Foundation of India, Gurugram, Haryana, India.
Health Economics, Financing and Policy, Public Health Foundation of India, Gurugram, Haryana, India.
PLoS One. 2019 Nov 13;14(11):e0224848. doi: 10.1371/journal.pone.0224848. eCollection 2019.
The key objective of this research was to generate new evidence on outpatient antibiotic prescription rate and patterns in the private sector in India. We used 12-month period (May 2013 to April 2014) medical audit dataset from IQVIA (formerly IMS Health). We coded the diagnosis provided in the medical audit data to International Statistical Classification of Diseases and Related Health Problems (ICD-10) and the prescribed antibiotics for the diagnosis to Anatomic Therapeutic Chemical (ATC) classification of World Health Organization (ATC index-2016). We calculated and reported antibiotic prescription rate per 1,000 persons per year, by age groups, antibiotic class and disease conditions. Our main findings are-approximately 519 million antibiotic prescriptions were dispensed in the private sector, which translates into 412 prescriptions per 1,000 persons per year. Majority of the antibiotic prescriptions were dispensed for acute upper respiratory infections (J06) (20.4%); unspecified acute lower respiratory infection (J22) (12.8%); disorders of urinary system (N39) (6.0%); cough (R05) (4.7%); and acute nasopharyngitis (J00) (4.6%) and highest antibiotic prescription rates were observed in the age group 0-4 years. To conclude our study reports first ever country level estimates of antibiotic prescription by antibiotic classes, age groups, and ICD-10 mapped disease conditions.
本研究的主要目标是提供有关印度私营部门门诊抗生素处方率和模式的新证据。我们使用了 IQVIA(前身为 IMS Health)的 12 个月(2013 年 5 月至 2014 年 4 月)医疗审计数据集。我们将医疗审计数据中提供的诊断编码为国际疾病分类(ICD-10),并将诊断中开出的抗生素编码为世界卫生组织(WHO)解剖治疗化学(ATC)分类(ATC 索引-2016)。我们按年龄组、抗生素类别和疾病状况计算并报告了每千人每年的抗生素处方率。我们的主要发现是-私营部门开出了约 5.19 亿份抗生素处方,相当于每千人每年 412 份处方。大多数抗生素处方用于急性上呼吸道感染(J06)(20.4%);未特指的急性下呼吸道感染(J22)(12.8%);泌尿系统疾病(N39)(6.0%);咳嗽(R05)(4.7%);急性鼻咽炎(J00)(4.6%),年龄组 0-4 岁的抗生素处方率最高。总之,我们的研究报告了首次按抗生素类别、年龄组和 ICD-10 映射疾病状况对印度抗生素处方进行的国家层面估计。